{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:48:20Z","timestamp":1778352500937,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1693,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Geriat. Psychiatry"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1002\/gps.2516","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T12:41:36Z","timestamp":1279716096000},"page":"206-213","source":"Crossref","is-referenced-by-count":23,"title":["Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment"],"prefix":"10.1002","volume":"26","author":[{"given":"C.","family":"Johansson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Ballard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Palmqvist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Minthon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Aarsland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Londos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"10.1002\/gps.2516-BIB1|cit1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1002\/gps.2516-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.20527","article-title":"A systematic review of prevalence studies of dementia in Parkinson's disease","volume":"20","author":"Aarsland","year":"2005","journal-title":"Mov Disord"},{"key":"10.1002\/gps.2516-BIB3|cit3","volume-title":"Diagnostic and Statistical Manual of Mental Disorder","author":"American Psychiatric Association (APA)","year":"1994"},{"key":"10.1002\/gps.2516-BIB4|cit4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/j.1600-0404.1997.tb00299.x","article-title":"The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies","volume":"96","author":"Ballard","year":"1997","journal-title":"Acta Neurol Scand"},{"key":"10.1002\/gps.2516-BIB5|cit5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/gps.1746","article-title":"Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease","volume":"22","author":"Burns","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/gps.2516-BIB6|cit6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1750-3639.2004.tb00082.x","article-title":"Abnormal metabotropic glutamate receptor expression and signaling in the cerebral cortex in diffuse Lewy body disease is associated with irregular alpha-synuclein\/phospholipase C (PLCbeta1) interactions","volume":"14","author":"Dalfo","year":"2004","journal-title":"Brain Pathol"},{"key":"10.1002\/gps.2516-BIB7|cit7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/archneur.58.3.427","article-title":"Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease","volume":"58","author":"Doody","year":"2001","journal-title":"Arch Neurol"},{"key":"10.1002\/gps.2516-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson's disease","volume":"351","author":"Emre","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1002\/gps.2516-BIB9|cit9","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/S0140-6736(05)67889-0","article-title":"Global prevalence of dementia: a Delphi consensus study","volume":"366","author":"Ferri","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/gps.2516-BIB10|cit10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"issue":"(Suppl 12)","key":"10.1002\/gps.2516-BIB11|cit11","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1002\/mds.20535","article-title":"How to diagnose dementia with Lewy bodies: state of the art","volume":"20","author":"Geser","year":"2005","journal-title":"Mov Disord"},{"key":"10.1002\/gps.2516-BIB12|cit12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/archneur.57.1.94","article-title":"Donepezil therapy in clinical practice: a randomized crossover study","volume":"57","author":"Greenberg","year":"2000","journal-title":"Arch Neurol"},{"key":"10.1002\/gps.2516-BIB13|cit13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000203887","article-title":"Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan","volume":"27","author":"Homma","year":"2009","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1002\/gps.2516-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/gps.993","article-title":"Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease","volume":"19","author":"Leroi","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/gps.2516-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1002\/mds.22495","article-title":"Randomized controlled trial of memantine in dementia associated with Parkinson's disease","volume":"24","author":"Leroi","year":"2009","journal-title":"Mov Disord"},{"key":"10.1002\/gps.2516-BIB16|cit16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s11055-009-9167-x","article-title":"Efficacy and safety of memantine in Lewy body dementia","volume":"39","author":"Levin","year":"2009","journal-title":"Neurosci Behav Physiol"},{"key":"10.1002\/gps.2516-BIB17|cit17","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1212\/01.wnl.0000256715.13907.d3","article-title":"DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers","volume":"68","author":"Lippa","year":"2007","journal-title":"Neurology"},{"key":"10.1002\/gps.2516-BIB18|cit18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2174\/1567205053585846","article-title":"The molecular basis of memantine action in Alzheimer's disease and other neurologic disorders: low-affinity, uncompetitive antagonism","volume":"2","author":"Lipton","year":"2005","journal-title":"Curr Alzheimer Res"},{"key":"10.1002\/gps.2516-BIB19|cit19","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","article-title":"Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop","volume":"9","author":"McKeith","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.1002\/gps.2516-BIB20|cit20","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(00)03399-7","article-title":"Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study","volume":"356","author":"McKeith","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/gps.2516-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","article-title":"Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium","volume":"65","author":"McKeith","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/gps.2516-BIB22|cit22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/gps.995","article-title":"What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia","volume":"18","author":"Minett","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/gps.2516-BIB23|cit23","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/mds.20700","article-title":"Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study","volume":"21","author":"Poewe","year":"2006","journal-title":"Mov Disord"},{"key":"10.1002\/gps.2516-BIB24|cit24","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1002\/gps.2516-BIB25|cit25","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/01.wnl.0000172351.95783.8e","article-title":"Delusions and hallucinations in dementia with Lewy bodies: worsening with memantine","volume":"65","author":"Ridha","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/gps.2516-BIB26|cit26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.3233\/JAD-2005-7403","article-title":"The use of memantine in dementia with Lewy bodies","volume":"7","author":"Sabbagh","year":"2005","journal-title":"J Alzheimers Dis"},{"issue":"(Suppl 2)","key":"10.1002\/gps.2516-BIB27|cit27","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1002\/gps.2516-BIB28|cit28","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/gps.2516-BIB29|cit29","first-page":"367","article-title":"Memantine: a review of studies into its safety and efficacy in treating Alzheimer's disease and other dementias","volume":"4","author":"Thomas","year":"2009","journal-title":"Clin Interv Aging"}],"container-title":["International Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fgps.2516","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/gps.2516\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T04:17:09Z","timestamp":1625285829000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/gps.2516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,12]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"URL":"https:\/\/doi.org\/10.1002\/gps.2516","relation":{},"ISSN":["0885-6230"],"issn-type":[{"value":"0885-6230","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1,12]]}}}